Armistice exercises remaining 54,000 pre-funded warrants; all warrants now fully exercised

HCW Biologics Inc.

On June 18, 2025, Armistice Capital Master Fund exercised Pre-Funded Warrants for 54,000 shares of HCW Biologics common stock.
With this exercise, all 513,140 Pre-Funded Warrants originally granted are fully exercised and none remain outstanding.
Exercise price was $0.0001 per share, with negligible cash proceeds to the Company.

item 8.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.